Janux Therapeutics, Inc.
Ticker: JANX
| Insider | Title |
|---|---|
| Advisors Llc Orbimed | 10% or greater ownership |
| Alana B. Mcnulty | Director |
| Andrew Hollman Meyer | Chief Business Officer |
| Bioventures I, Lp Avalon | 10% or greater ownership |
| Bioventures Spv I, L.p. Avalon | 10% or greater ownership |
| Byron Robinson | Chief Strategy Officer |
| Capital Gp Vii Llc Orbimed | 10% or greater ownership |
| Capital Gp Viii Llc Orbimed | Director |
| Capital Healthcare Fund Lp Ra | Director, 10% or greater ownership |
| Capital Management, L.p. Ra | Director, 10% or greater ownership |
| Capital Nexus Fund Ii, L.p. Ra | Director |
| Charles M. Winter | Chief Technical Officer |
| Corp Bregua | 10% or greater ownership |
| David Alan Campbell | President and CEO, Director |
| Eric Dobmeier | Director |
| Genesis Gp Llc Orbimed | 10% or greater ownership |
| Jake Simson | Director |
| Jay Lichter | 10% or greater ownership |
| Maria Dobek | Vice President, Accounting |
| Natasha Hernday | Director |
| Peter A. Thompson | Director |
| Peter Kolchinsky | Director, 10% or greater ownership |
| Rajeev M. Shah | Director, 10% or greater ownership |
| Ronald W Barrett | Director |
| Shahram Salek-ardakani | Chief Scientific Officer |
| Sheila Gujrathi | Director |
| Stefan Heller | Director |
| Thomas Diraimondo | Chief Scientific Officer |
| Tighe Reardon | Acting Chief Financial Officer |
| Ventures Xi, L.p. Avalon | 10% or greater ownership |
| Vickie L Capps | Director |
| Wayne Godfrey | Chief Medical Officer |
| Winston Kung | Director |